These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 15550578

  • 21. Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.
    Buzdar A.
    Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S42-8. PubMed ID: 12756078
    [Abstract] [Full Text] [Related]

  • 22. Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.
    Grana G.
    J Surg Oncol; 2006 Jun 01; 93(7):585-92. PubMed ID: 16705732
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Anastrozole for breast cancer: recent advances and ongoing challenges.
    Buzdar AU.
    Expert Rev Anticancer Ther; 2006 Jun 01; 6(6):839-48. PubMed ID: 16761927
    [Abstract] [Full Text] [Related]

  • 25. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
    Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, ATAC Trialists' Group.
    Lancet; 2006 Jun 01; 365(9453):60-2. PubMed ID: 15639680
    [Abstract] [Full Text] [Related]

  • 26. New developments in the treatment of postmenopausal breast cancer.
    Howell A.
    Trends Endocrinol Metab; 2005 Nov 01; 16(9):420-8. PubMed ID: 16213745
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now?
    Baum M.
    Eur J Cancer; 2005 Aug 01; 41(12):1667-77. PubMed ID: 16046117
    [Abstract] [Full Text] [Related]

  • 29. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R.
    Eur J Surg Oncol; 2008 Jul 01; 34(7):746-55. PubMed ID: 18296017
    [Abstract] [Full Text] [Related]

  • 30. Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
    Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, Rücklinger E, Samonigg H, Austrian Breast and Colorectal Cancer Study Group.
    J Natl Cancer Inst; 2007 Dec 19; 99(24):1845-53. PubMed ID: 18073378
    [Abstract] [Full Text] [Related]

  • 31. Hormonal therapy in early and advanced breast cancer.
    Buzdar AU.
    Breast J; 2004 Dec 19; 10 Suppl 1():S19-21. PubMed ID: 14984485
    [Abstract] [Full Text] [Related]

  • 32. Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention.
    Nabholtz JM.
    Oncology; 2006 Dec 19; 70(1):1-12. PubMed ID: 16439860
    [Abstract] [Full Text] [Related]

  • 33. Role of anti-aromatase agents in postmenopausal advanced breast cancer.
    Murray R.
    Cancer Chemother Pharmacol; 2001 Oct 19; 48(4):259-65. PubMed ID: 11710624
    [Abstract] [Full Text] [Related]

  • 34. The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer.
    Hamilton A, Piccart M.
    Ann Oncol; 1999 Apr 19; 10(4):377-84. PubMed ID: 10370778
    [Abstract] [Full Text] [Related]

  • 35. The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
    Mouridsen HT, Robert NJ.
    Eur J Cancer; 2005 Aug 19; 41(12):1678-89. PubMed ID: 16098456
    [Abstract] [Full Text] [Related]

  • 36. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.
    Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T, ATAC Trialists' Group.
    Lancet; 2002 Jun 22; 359(9324):2131-9. PubMed ID: 12090977
    [Abstract] [Full Text] [Related]

  • 37. The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.
    Morandi P, Rouzier R, Altundag K, Buzdar AU, Theriault RL, Hortobagyi G.
    Cancer; 2004 Oct 01; 101(7):1482-9. PubMed ID: 15378476
    [Abstract] [Full Text] [Related]

  • 38. The adjuvant endocrine treatment revolution: focus on anastrozole.
    Jakesz R.
    Expert Opin Drug Metab Toxicol; 2006 Apr 01; 2(2):301-12. PubMed ID: 16866615
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Letrozole: a review of its use in postmenopausal women with breast cancer.
    Simpson D, Curran MP, Perry CM.
    Drugs; 2004 Apr 01; 64(11):1213-30. PubMed ID: 15161328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.